+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Next-Generation Biomanufacturing Market by Product Type, Technology, Process Stage, End User, Operation Scale, Cell Line, Process Mode - Global Forecast 2025-2030- Product Image
Next-Generation Biomanufacturing Market by Product Type, Technology, Process Stage, End User, Operation Scale, Cell Line, Process Mode - Global Forecast 2025-2030- Product Image
Sale

Next-Generation Biomanufacturing Market by Product Type, Technology, Process Stage, End User, Operation Scale, Cell Line, Process Mode - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 193 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 5925154
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The next-generation biomanufacturing market is redefining bioprocesses, enabling organizations to accelerate therapeutic innovation while optimizing operational efficiency. Senior decision-makers face high-stakes challenges as new technologies, regulatory shifts, and global trends rapidly reshape production and commercialization pathways in this domain.

Market Snapshot: Next-Generation Biomanufacturing Market Overview

The Next-Generation Biomanufacturing Market grew from USD 20.69 billion in 2024 to USD 22.66 billion in 2025. It is expected to continue growing at a CAGR of 9.15%, reaching USD 35.00 billion by 2030. This expansion reflects a move toward next-generation production strategies and integrated solutions, with decision-makers seeking greater flexibility, scalability, and cost-efficiency in response to changing regulatory environments, pandemic preparedness needs, and demand for innovative therapies.

Scope & Segmentation of the Market

  • Product Types: Cell and gene therapies including CAR-T, cell therapies, gene editing; enzymes for diagnostics and industrial applications; monoclonal antibodies applied in autoimmune, infectious disease, and oncology; recombinant proteins like cytokines and growth factors; and diverse vaccine platforms including mRNA, subunit, and viral vector vaccines.
  • Technologies: Cell-free systems using expression kits and high-throughput synthesis; continuous bioprocessing featuring chromatography and perfusion; modular and skid-mounted facilities; single-use systems such as bioreactors and tubing.
  • Process Stages: Upstream operations covering bioreactor management, cell culture, and media preparation; downstream purification and filtration; formulation including fill-and-finish, lyophilization, and packaging.
  • End Users: Academic and research institutions; biotech and pharmaceutical companies; and contract manufacturing organizations.
  • Operational Scales: Pilot, clinical, and commercial scale production.
  • Cell Lines: CHO (including DG44 and K1 variants), E. coli (BL21, K12), and yeast types such as Pichia pastoris and Saccharomyces cerevisiae.
  • Process Modes: Batch, fed-batch, continuous, and perfusion production strategies.
  • Regional Segments: Americas (with detailed insight into U.S. states and Latin American countries), Europe, Middle East & Africa (key European markets, Gulf states, and African leaders), and Asia-Pacific (including China, India, Japan, Southeast Asia, and Oceania).
  • Companies Covered: Novozymes A/S, Koninklijke DSM N.V., Evonik Industries AG, Ginkgo Bioworks Holdings, Inc., Amyris, Inc., Codexis, Inc., Zymergen Inc., Genomatica, Inc., Evolva Holding SA, LanzaTech, Inc.

Key Takeaways for Decision-Makers

  • Advanced digitalization and process analytics are unlocking real-time monitoring, reducing deviations, and enabling predictive maintenance across both R&D and production lines.
  • Continuous and modular bioprocessing are enabling organizations to scale manufacturing rapidly without heavy capital outlays linked to traditional facilities.
  • Strategic partnerships between technology providers, contract manufacturers, and academic research centers are streamlining both therapeutic innovation and market access for novel biologics.
  • The rise of single-use systems is minimizing contamination risks and simplifying validation protocols, which is essential for the rapid deployment of new therapies and pandemic responses.
  • Segment-specific approaches, such as the use of cell-free platforms and high-value monoclonal antibody applications, allow organizations to address niche market demands with targeted efficiency.
  • Diversified supply chains and near-shoring strategies are increasingly used to mitigate operational risks tied to geopolitical and regulatory uncertainty.

Tariff Impact: Navigating U.S. Revisions in 2025

Forthcoming U.S. tariff revisions are influencing cost structures throughout biomanufacturing, amplifying input expenses for raw materials and single-use plastics. Manufacturers are responding through risk-adjusted sourcing, reassessing domestic versus imported machinery, and accelerating modular domestic facility expansion. Strategic alliances and scenario planning are becoming crucial to maintain production continuity and competitive advantage in the face of evolving trade dynamics.

Methodology & Data Sources

This report employs structured interviews with senior executives, process engineers, and R&D leaders across the sector. Insights are supplemented by regulatory roundtable consultations, extensive secondary review of scientific literature, patent filings, and market databases. Analytical frameworks include SWOT and PESTEL assessments validated via expert panel review and data triangulation.

Why This Report Matters

  • Enables executive teams to make informed investments and operational decisions amid rapidly evolving manufacturing paradigms and market requirements.
  • Delivers actionable guidance on integrating new technologies, navigating regulatory changes, and building resilient, scalable supply chains.
  • Supports long-term value creation through deep segmentation, competitive analysis, and regional opportunity mapping—tailored for senior business leaders.

Conclusion

The next-generation biomanufacturing market is defined by rapid technological, regulatory, and strategic shifts. Leaders who embrace integrated, data-driven, and collaborative approaches will capture opportunities in this dynamic, globally interconnected sector.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Integration of single-use bioreactor systems to accelerate flexible biomanufacturing capacity
5.2. Utilization of CRISPR gene editing platforms to optimize microbial cell factories for high-yield protein therapeutics
5.3. Adoption of continuous perfusion bioprocessing techniques to improve product consistency and reduce costs
5.4. Implementation of AI-driven digital twins for real-time process monitoring and predictive bioprocess control
5.5. Development of modular microfluidic platforms for high-throughput screening of cell line performance
5.6. Incorporation of biodegradable nanomaterials for targeted drug delivery in precision biomedicine manufacturing
5.7. Sustainable feedstock sourcing from lignocellulosic biomass for microbial fermentation to produce bio-based chemicals
5.8. Expansion of cell-free protein synthesis systems for rapid on-demand biologics production at point of care
5.9. Scale-up of vaccine manufacturing using mRNA lipid nanoparticle technologies across distributed production networks
5.10. Regulatory harmonization for advanced therapy medicinal products to accelerate global biomanufacturing approvals
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Next-Generation Biomanufacturing Market, by Product Type
8.1. Introduction
8.2. Cell And Gene Therapies
8.2.1. Car-T Therapies
8.2.2. Cell Therapies
8.2.3. Gene Editing Therapies
8.3. Enzymes
8.3.1. Diagnostic Enzymes
8.3.2. Industrial Enzymes
8.4. Monoclonal Antibodies
8.4.1. Autoimmune
8.4.2. Infectious Diseases
8.4.3. Oncology
8.5. Recombinant Proteins
8.5.1. Cytokines
8.5.2. Growth Factors
8.5.3. Hormones
8.6. Vaccines
8.6.1. Live Attenuated Vaccines
8.6.2. Mrna Vaccines
8.6.3. Subunit Vaccines
8.6.4. Viral Vector Vaccines
9. Next-Generation Biomanufacturing Market, by Technology
9.1. Introduction
9.2. Cell-Free Systems
9.2.1. Cell-Free Expression Kits
9.2.2. Cell-Free Synthesis Platforms
9.3. Continuous Bioprocessing
9.3.1. Continuous Chromatography
9.3.2. Inline Monitoring Systems
9.3.3. Perfusion Systems
9.4. Modular Facilities
9.4.1. Prefabricated Modules
9.4.2. Skid-Mounted Systems
9.5. Single-Use Systems
9.5.1. Single-Use Bags
9.5.2. Single-Use Bioreactors
9.5.3. Single-Use Tubing And Connectors
10. Next-Generation Biomanufacturing Market, by Process Stage
10.1. Introduction
10.2. Downstream Processing
10.2.1. Chromatography
10.2.2. Filtration
10.2.3. Purification
10.3. Formulation
10.3.1. Fill And Finish
10.3.2. Lyophilization
10.3.3. Packaging
10.4. Upstream Processing
10.4.1. Bioreactor Operation
10.4.2. Cell Culture
10.4.3. Media Preparation
11. Next-Generation Biomanufacturing Market, by End User
11.1. Introduction
11.2. Academic And Research Institutions
11.3. Biotech Companies
11.4. Contract Manufacturing Organizations
11.5. Pharmaceutical Companies
12. Next-Generation Biomanufacturing Market, by Operation Scale
12.1. Introduction
12.2. Clinical Scale
12.3. Commercial Scale
12.4. Pilot Scale
13. Next-Generation Biomanufacturing Market, by Cell Line
13.1. Introduction
13.2. Cho Cell
13.2.1. Cho-DG44
13.2.2. Cho-K1
13.3. E. Coli
13.3.1. Bl21
13.3.2. K12
13.4. Yeast
13.4.1. Pichia Pastoris
13.4.2. Saccharomyces Cerevisiae
14. Next-Generation Biomanufacturing Market, by Process Mode
14.1. Introduction
14.2. Batch
14.3. Continuous
14.4. Fed Batch
14.5. Perfusion
15. Americas Next-Generation Biomanufacturing Market
15.1. Introduction
15.2. United States
15.3. Canada
15.4. Mexico
15.5. Brazil
15.6. Argentina
16. Europe, Middle East & Africa Next-Generation Biomanufacturing Market
16.1. Introduction
16.2. United Kingdom
16.3. Germany
16.4. France
16.5. Russia
16.6. Italy
16.7. Spain
16.8. United Arab Emirates
16.9. Saudi Arabia
16.10. South Africa
16.11. Denmark
16.12. Netherlands
16.13. Qatar
16.14. Finland
16.15. Sweden
16.16. Nigeria
16.17. Egypt
16.18. Turkey
16.19. Israel
16.20. Norway
16.21. Poland
16.22. Switzerland
17. Asia-Pacific Next-Generation Biomanufacturing Market
17.1. Introduction
17.2. China
17.3. India
17.4. Japan
17.5. Australia
17.6. South Korea
17.7. Indonesia
17.8. Thailand
17.9. Philippines
17.10. Malaysia
17.11. Singapore
17.12. Vietnam
17.13. Taiwan
18. Competitive Landscape
18.1. Market Share Analysis, 2024
18.2. FPNV Positioning Matrix, 2024
18.3. Competitive Analysis
18.3.1. Novozymes A/S
18.3.2. Koninklijke DSM N.V.
18.3.3. Evonik Industries AG
18.3.4. Ginkgo Bioworks Holdings, Inc.
18.3.5. Amyris, Inc.
18.3.6. Codexis, Inc.
18.3.7. Zymergen Inc.
18.3.8. Genomatica, Inc.
18.3.9. Evolva Holding SA
18.3.10. LanzaTech, Inc.
19. ResearchAI
20. ResearchStatistics
21. ResearchContacts
22. ResearchArticles
23. Appendix
List of Figures
FIGURE 1. NEXT-GENERATION BIOMANUFACTURING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 8. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2024 VS 2030 (%)
FIGURE 14. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2024 VS 2030 (%)
FIGURE 18. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. ASIA-PACIFIC NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. ASIA-PACIFIC NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. NEXT-GENERATION BIOMANUFACTURING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. NEXT-GENERATION BIOMANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 29. NEXT-GENERATION BIOMANUFACTURING MARKET: RESEARCHAI
FIGURE 30. NEXT-GENERATION BIOMANUFACTURING MARKET: RESEARCHSTATISTICS
FIGURE 31. NEXT-GENERATION BIOMANUFACTURING MARKET: RESEARCHCONTACTS
FIGURE 32. NEXT-GENERATION BIOMANUFACTURING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. NEXT-GENERATION BIOMANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CAR-T THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CAR-T THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY GENE EDITING THERAPIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY GENE EDITING THERAPIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTIC ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DIAGNOSTIC ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY INDUSTRIAL ENZYMES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY INDUSTRIAL ENZYMES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY AUTOIMMUNE, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ONCOLOGY, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CYTOKINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY HORMONES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY HORMONES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY LIVE ATTENUATED VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MRNA VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MRNA VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SUBUNIT VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VIRAL VECTOR VACCINES, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VIRAL VECTOR VACCINES, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE EXPRESSION KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE EXPRESSION KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYNTHESIS PLATFORMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYNTHESIS PLATFORMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY INLINE MONITORING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY INLINE MONITORING SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PERFUSION SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PERFUSION SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2018-2024 (USD MILLION)
TABLE 80. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2025-2030 (USD MILLION)
TABLE 81. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 82. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 83. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PREFABRICATED MODULES, BY REGION, 2018-2024 (USD MILLION)
TABLE 84. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PREFABRICATED MODULES, BY REGION, 2025-2030 (USD MILLION)
TABLE 85. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SKID-MOUNTED SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 86. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SKID-MOUNTED SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 87. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2018-2024 (USD MILLION)
TABLE 88. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2025-2030 (USD MILLION)
TABLE 89. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 90. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 91. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE BAGS, BY REGION, 2018-2024 (USD MILLION)
TABLE 92. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE BAGS, BY REGION, 2025-2030 (USD MILLION)
TABLE 93. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE BIOREACTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 94. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE BIOREACTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 95. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE TUBING AND CONNECTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 96. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE TUBING AND CONNECTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 97. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 98. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 99. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2024 (USD MILLION)
TABLE 100. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2025-2030 (USD MILLION)
TABLE 101. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 102. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 103. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2018-2024 (USD MILLION)
TABLE 104. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHROMATOGRAPHY, BY REGION, 2025-2030 (USD MILLION)
TABLE 105. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FILTRATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 106. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FILTRATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 107. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PURIFICATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 108. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PURIFICATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 109. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 110. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 111. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 112. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 113. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FILL AND FINISH, BY REGION, 2018-2024 (USD MILLION)
TABLE 114. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FILL AND FINISH, BY REGION, 2025-2030 (USD MILLION)
TABLE 115. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY LYOPHILIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 116. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY LYOPHILIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 117. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2018-2024 (USD MILLION)
TABLE 118. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PACKAGING, BY REGION, 2025-2030 (USD MILLION)
TABLE 119. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 120. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 121. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2018-2024 (USD MILLION)
TABLE 122. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, BY REGION, 2025-2030 (USD MILLION)
TABLE 123. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BIOREACTOR OPERATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 124. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BIOREACTOR OPERATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 125. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2024 (USD MILLION)
TABLE 126. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL CULTURE, BY REGION, 2025-2030 (USD MILLION)
TABLE 127. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MEDIA PREPARATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 128. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MEDIA PREPARATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 129. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 130. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 131. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 132. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 133. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 134. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 135. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 136. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BIOTECH COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 137. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
TABLE 138. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTRACT MANUFACTURING ORGANIZATIONS, BY REGION, 2025-2030 (USD MILLION)
TABLE 139. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 140. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 141. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2018-2024 (USD MILLION)
TABLE 142. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2025-2030 (USD MILLION)
TABLE 143. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CLINICAL SCALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 144. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CLINICAL SCALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 145. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COMMERCIAL SCALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 146. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COMMERCIAL SCALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 147. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PILOT SCALE, BY REGION, 2018-2024 (USD MILLION)
TABLE 148. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PILOT SCALE, BY REGION, 2025-2030 (USD MILLION)
TABLE 149. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2024 (USD MILLION)
TABLE 150. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2025-2030 (USD MILLION)
TABLE 151. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, BY REGION, 2018-2024 (USD MILLION)
TABLE 152. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, BY REGION, 2025-2030 (USD MILLION)
TABLE 153. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO-DG44, BY REGION, 2018-2024 (USD MILLION)
TABLE 154. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO-DG44, BY REGION, 2025-2030 (USD MILLION)
TABLE 155. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO-K1, BY REGION, 2018-2024 (USD MILLION)
TABLE 156. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO-K1, BY REGION, 2025-2030 (USD MILLION)
TABLE 157. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, 2018-2024 (USD MILLION)
TABLE 158. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, 2025-2030 (USD MILLION)
TABLE 159. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, BY REGION, 2018-2024 (USD MILLION)
TABLE 160. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, BY REGION, 2025-2030 (USD MILLION)
TABLE 161. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BL21, BY REGION, 2018-2024 (USD MILLION)
TABLE 162. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BL21, BY REGION, 2025-2030 (USD MILLION)
TABLE 163. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY K12, BY REGION, 2018-2024 (USD MILLION)
TABLE 164. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY K12, BY REGION, 2025-2030 (USD MILLION)
TABLE 165. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, 2018-2024 (USD MILLION)
TABLE 166. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, 2025-2030 (USD MILLION)
TABLE 167. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, BY REGION, 2018-2024 (USD MILLION)
TABLE 168. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, BY REGION, 2025-2030 (USD MILLION)
TABLE 169. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PICHIA PASTORIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 170. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PICHIA PASTORIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 171. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SACCHAROMYCES CEREVISIAE, BY REGION, 2018-2024 (USD MILLION)
TABLE 172. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SACCHAROMYCES CEREVISIAE, BY REGION, 2025-2030 (USD MILLION)
TABLE 173. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, 2018-2024 (USD MILLION)
TABLE 174. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, 2025-2030 (USD MILLION)
TABLE 175. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2018-2024 (USD MILLION)
TABLE 176. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2025-2030 (USD MILLION)
TABLE 177. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 178. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY BATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 179. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS, BY REGION, 2018-2024 (USD MILLION)
TABLE 180. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS, BY REGION, 2025-2030 (USD MILLION)
TABLE 181. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FED BATCH, BY REGION, 2018-2024 (USD MILLION)
TABLE 182. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FED BATCH, BY REGION, 2025-2030 (USD MILLION)
TABLE 183. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PERFUSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 184. GLOBAL NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PERFUSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 185. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 186. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 187. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2024 (USD MILLION)
TABLE 188. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2025-2030 (USD MILLION)
TABLE 189. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 190. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 191. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 192. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 193. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 194. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 195. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 196. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 197. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 198. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 199. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 200. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 201. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2018-2024 (USD MILLION)
TABLE 202. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2025-2030 (USD MILLION)
TABLE 203. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2018-2024 (USD MILLION)
TABLE 204. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2025-2030 (USD MILLION)
TABLE 205. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 206. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 207. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2024 (USD MILLION)
TABLE 208. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2025-2030 (USD MILLION)
TABLE 209. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 210. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 211. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 212. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 213. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 214. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 215. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 216. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 217. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2018-2024 (USD MILLION)
TABLE 218. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2025-2030 (USD MILLION)
TABLE 219. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2024 (USD MILLION)
TABLE 220. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2025-2030 (USD MILLION)
TABLE 221. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, 2018-2024 (USD MILLION)
TABLE 222. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, 2025-2030 (USD MILLION)
TABLE 223. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, 2018-2024 (USD MILLION)
TABLE 224. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, 2025-2030 (USD MILLION)
TABLE 225. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, 2018-2024 (USD MILLION)
TABLE 226. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, 2025-2030 (USD MILLION)
TABLE 227. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2018-2024 (USD MILLION)
TABLE 228. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2025-2030 (USD MILLION)
TABLE 229. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 230. AMERICAS NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 231. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 232. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 233. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2024 (USD MILLION)
TABLE 234. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2025-2030 (USD MILLION)
TABLE 235. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 236. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 237. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 238. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 239. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 240. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 241. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 242. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 243. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 244. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 245. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 246. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL-FREE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 247. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2018-2024 (USD MILLION)
TABLE 248. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CONTINUOUS BIOPROCESSING, 2025-2030 (USD MILLION)
TABLE 249. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2018-2024 (USD MILLION)
TABLE 250. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MODULAR FACILITIES, 2025-2030 (USD MILLION)
TABLE 251. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2018-2024 (USD MILLION)
TABLE 252. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY SINGLE-USE SYSTEMS, 2025-2030 (USD MILLION)
TABLE 253. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2018-2024 (USD MILLION)
TABLE 254. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS STAGE, 2025-2030 (USD MILLION)
TABLE 255. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 256. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY DOWNSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 257. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, 2018-2024 (USD MILLION)
TABLE 258. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY FORMULATION, 2025-2030 (USD MILLION)
TABLE 259. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2018-2024 (USD MILLION)
TABLE 260. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY UPSTREAM PROCESSING, 2025-2030 (USD MILLION)
TABLE 261. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 262. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 263. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2018-2024 (USD MILLION)
TABLE 264. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY OPERATION SCALE, 2025-2030 (USD MILLION)
TABLE 265. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2018-2024 (USD MILLION)
TABLE 266. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL LINE, 2025-2030 (USD MILLION)
TABLE 267. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, 2018-2024 (USD MILLION)
TABLE 268. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CHO CELL, 2025-2030 (USD MILLION)
TABLE 269. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, 2018-2024 (USD MILLION)
TABLE 270. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY E. COLI, 2025-2030 (USD MILLION)
TABLE 271. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, 2018-2024 (USD MILLION)
TABLE 272. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY YEAST, 2025-2030 (USD MILLION)
TABLE 273. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2018-2024 (USD MILLION)
TABLE 274. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PROCESS MODE, 2025-2030 (USD MILLION)
TABLE 275. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 276. UNITED STATES NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 277. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
TABLE 278. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY PRODUCT TYPE, 2025-2030 (USD MILLION)
TABLE 279. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2018-2024 (USD MILLION)
TABLE 280. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY CELL AND GENE THERAPIES, 2025-2030 (USD MILLION)
TABLE 281. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2018-2024 (USD MILLION)
TABLE 282. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY ENZYMES, 2025-2030 (USD MILLION)
TABLE 283. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2018-2024 (USD MILLION)
TABLE 284. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY MONOCLONAL ANTIBODIES, 2025-2030 (USD MILLION)
TABLE 285. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2018-2024 (USD MILLION)
TABLE 286. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY RECOMBINANT PROTEINS, 2025-2030 (USD MILLION)
TABLE 287. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2018-2024 (USD MILLION)
TABLE 288. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY VACCINES, 2025-2030 (USD MILLION)
TABLE 289. CANADA NEXT-GENERATION BIOMANUFACTURING MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE

Samples

Loading
LOADING...

Companies Mentioned

The major companies profiled in this Next-Generation Biomanufacturing market report include:
  • Novozymes A/S
  • Koninklijke DSM N.V.
  • Evonik Industries AG
  • Ginkgo Bioworks Holdings, Inc.
  • Amyris, Inc.
  • Codexis, Inc.
  • Zymergen Inc.
  • Genomatica, Inc.
  • Evolva Holding SA
  • LanzaTech, Inc.

Table Information

Report AttributeDetails
No. of Pages193
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 22.66 Billion
Forecasted Market Value ( USD ) by 2030 $ 35 Billion
Compound Annual Growth Rate9.1%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Biomanufacturing Viral Detection & Quantification Market by Product (Instruments & Systems, Reagents & Kits, Software & Services), Technology (Crispr Technology, Immunoassay, Next Generation Sequencing), Application, End User, Sample Type - Global Forecast 2025-2030 - Product Image

Biomanufacturing Viral Detection & Quantification Market by Product (Instruments & Systems, Reagents & Kits, Software & Services), Technology (Crispr Technology, Immunoassay, Next Generation Sequencing), Application, End User, Sample Type - Global Forecast 2025-2030

  • Report
  • 188 Pages
  • Global
From
Vital Proteins for Biomanufacturing Market by Product Type (Collagen, Gelatin, Hydrolysates), Source (Bovine, Marine, Porcine), Application, End Use, Distribution Channel - Global Forecast 2025-2030 - Product Image

Vital Proteins for Biomanufacturing Market by Product Type (Collagen, Gelatin, Hydrolysates), Source (Bovine, Marine, Porcine), Application, End Use, Distribution Channel - Global Forecast 2025-2030

  • Report
  • 193 Pages
  • Global
From
Biomanufacturing - Global Strategic Business Report - Product Image

Biomanufacturing - Global Strategic Business Report

  • Report
  • 375 Pages
  • Global
From
Digital Biomanufacturing - Global Strategic Business Report - Product Image

Digital Biomanufacturing - Global Strategic Business Report

  • Report
  • 341 Pages
  • Global
From
The Global Market for Industrial Biomanufacturing 2025-2035 - Product Image

The Global Market for Industrial Biomanufacturing 2025-2035

  • Report
  • 1159 Pages
  • Global

About the Next Generation Biomanufacturing Market

The Next Generation Biomanufacturing market is a subset of the biotechnology industry that focuses on the development of advanced manufacturing technologies for the production of biopharmaceuticals. This includes the use of cell and gene therapies, as well as the development of novel bioprocessing techniques. These technologies are used to improve the efficiency and cost-effectiveness of biopharmaceutical production, while also reducing the environmental impact of the process. The Next Generation Biomanufacturing market is driven by the increasing demand for biopharmaceuticals, as well as the need to reduce the cost of production. This has led to the development of new technologies such as single-use bioreactors, automated bioprocessing systems, and advanced analytics. These technologies are being used to improve the efficiency and cost-effectiveness of biopharmaceutical production, while also reducing the environmental impact of the process. Some of the companies in the Next Generation Biomanufacturing market include Thermo Fisher Scientific, Merck KGaA, GE Healthcare, Lonza, and Sartorius AG. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.